SEC Filings

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.

Print Print   Email Email

SEC Filings

  
Filing Description Date Filed Sorted Descending Size  
4 levy, harold j Mar 10, 2010 20.6 KB Add to Briefcase
SC TO-I/A other Mar 8, 2010 55.6 KB Add to Briefcase
8-K current report Mar 8, 2010 35.1 KB Add to Briefcase
4 tooman, craig a Feb 26, 2010 21.6 KB Add to Briefcase
4 horak, ivan d Feb 24, 2010 21.3 KB Add to Briefcase
SC TO-I/A other Feb 23, 2010 36.1 KB Add to Briefcase
8-K current report Feb 23, 2010 37.3 KB Add to Briefcase
SC 13D/A amended general statement of beneficial ownership Feb 22, 2010 55.9 KB Add to Briefcase
8-K current report Feb 17, 2010 86.9 KB Add to Briefcase
SC 13G statement of beneficial ownership Feb 16, 2010 28.7 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 16, 2010 28.3 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 58.5 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 20.7 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 12, 2010 37.9 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 11, 2010 31.0 KB Add to Briefcase
SC 13G statement of beneficial ownership Feb 5, 2010 88.2 KB Add to Briefcase
8-K current report Feb 5, 2010 20.3 KB Add to Briefcase
SC TO-I other Feb 5, 2010 226.0 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 2, 2010 23.1 KB Add to Briefcase
SC 13G/A amended statement of beneficial ownership Feb 2, 2010 55.0 KB Add to Briefcase
Showing 1-20 of 948 Page: 1 2 3 ... 48  Next 20
Add to Briefcase = add filing to Briefcase
Search
(ENZN) NASDAQ
Last Trade 10.310
Change(%) price 0.46
Volume 1,303,400
Mar 10, 2010 4:00 PM ET

Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.

click here to sign up

News

  • Details on upcoming events are not yet available.
    click here to be notified of all upcoming events.

  • subscribe to our news feed


    Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.

  • 03-08-2010

    Enzon's Debt is Reduced by $116 Million

    ­ ­ --Debt converted into an additional 13.5 million shares--
    ­ ­

    click here for more information

  • 02-24-2010

    Enzon Opens Pediatric Study of PEG-SN38

    ­ ­ ­ ­

    click here for more information

  • 02-22-2010

    Enzon Board of Directors Appoints Executive Committee

    ­ ­ Jeffrey Buchalter Steps Down as CEO of Enzon
    ­ ­

    click here for more information

  • 02-17-2010

    Enzon Reports 2009 Results

    ­ ­ --Sale of Specialty Pharmaceutical Business brings over $300 million in value--
    ­ ­

    click here for more information